SCHEMBL3614775

SCHEMBL3614775

N[C@H]1CN(Cc2ccccc2)CCN(Cc2ccccc2)C1=O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.50
TACR1 P25103 5/20 0.49
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
POLB P06746 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MCHR1 Q99705 1/20 0.44
MC4R P32245 1/20 0.44
DRD3 P35462 1/20 0.43
KCNH2 Q12809 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13875780 1.00 SIGMAR1 (0.50) SIGMAR1TACR1KMT2AMEN1NPC1
SCHEMBL4224776 0.81 ALDH1A1 (0.47) KMT2AMEN1CYP2D6CYP2C19POLB
SCHEMBL7933318 0.81 ALDH1A1 (0.47) KMT2AMEN1CYP2D6CYP2C19POLB
SCHEMBL4224772 0.81 ALDH1A1 (0.47) KMT2AMEN1CYP2D6CYP2C19POLB
Hydrochloric Acid SCHEMBL7927419 0.80 ALDH1A1 (0.46) KMT2AMEN1CYP2D6CYP2C19POLB
Hydrochloric Acid SCHEMBL7933795 0.80 ALDH1A1 (0.46) KMT2AMEN1CYP2D6CYP2C19POLB
Hydrochloric Acid SCHEMBL6818480 0.80 ALDH1A1 (0.46) KMT2AMEN1CYP2D6CYP2C19POLB
SCHEMBL13547184 0.78 HDAC1 (0.46) SIGMAR1TACR1KMT2ACYP2D6CYP2C19
SCHEMBL6202280 0.78 L3MBTL1 (0.51) KMT2AMEN1CYP2D6CYP2C19POLB
SCHEMBL6325124 0.77 NPC1 (0.47) SIGMAR1TACR1KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100009957-A1 NOVEL INHIBITORS OF BETA-LACTAMASE MERCK SHARP & DOHME CORP. 2010-01-14 US disclosed
US-20100009957-A1 NOVEL INHIBITORS OF BETA-LACTAMASE MERCK SHARP & DOHME CORP. 2010-01-14 US disclosed
US-20100009957-A1 NOVEL INHIBITORS OF BETA-LACTAMASE MERCK SHARP & DOHME CORP. 2010-01-14 US disclosed
EP-2069347-A2 NOVEL INHIBITORS OF BETA-LACTAMASE Merck & Co., Inc. (US) 2009-06-17 EP disclosed
WO-2008039420-A2 NOVEL INHIBITORS OF BETA-LACTAMASE MERCK & CO., INC. (US) 2008-04-03 WO disclosed
WO-2008039420-A2 NOVEL INHIBITORS OF BETA-LACTAMASE MERCK & CO., INC. (US) 2008-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009957-A1 NOVEL INHIBITORS OF BETA-LACTAMASE MGAM, SI, MGAM2 SIGMAR1 2341/4885TACR1 4201/4885KMT2A 1484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.